×
Shopping Cart
×
Quote List
Inquiry

Cell-Penetrating Peptides


Product Name Catalog Unit Size Price
CooP CDCCP23-102L 50 mg, 100 mg, 250 mg INQUIRY
Activable Cell-Penetrating Peptide (ACCP) CDCCP23-103L 50 mg, 100 mg, 250 mg INQUIRY
NLS (PKKKRKV) (TFA) CDCCP23-104L 50 mg, 100 mg, 250 mg INQUIRY
Myristoyl-MEK1 Derived Peptide Inhibitor 1 CDCCP23-105L 50 mg, 100 mg, 250 mg INQUIRY
EB1 Peptide CDCCP23-106L 50 mg, 100 mg, 250 mg INQUIRY
NLS (PKKKRKV) CDCCP23-107L 50 mg, 100 mg, 250 mg INQUIRY
HN-1 CDCCP23-108L 50 mg, 100 mg, 250 mg INQUIRY
TAT (48-57) (TFA) CDCCP23-109L 50 mg, 100 mg, 250 mg INQUIRY
AGR CDCCP23-110L 50 mg, 100 mg, 250 mg INQUIRY
TAT-Amide TFA CDCCP23-111L 50 mg, 100 mg, 250 mg INQUIRY
Tumor Targeted Pro-Apoptotic Peptide CDCCP23-112L 50 mg, 100 mg, 250 mg INQUIRY
SynB1 CDCCP23-113L 50 mg, 100 mg, 250 mg INQUIRY
HAP-1 CDCCP23-114L 50 mg, 100 mg, 250 mg INQUIRY
11R-VIVIT CDCCP23-115L 50 mg, 100 mg, 250 mg INQUIRY
CGYGPKKKRKVGG CDCCP23-116L 50 mg, 100 mg, 250 mg INQUIRY
RGDV CDCCP23-117L 50 mg, 100 mg, 250 mg INQUIRY
pH-Low Insertion Peptide CDCCP23-118L 50 mg, 100 mg, 250 mg INQUIRY
Cys(Npys)-TAT (47-57) CDCCP23-119L 50 mg, 100 mg, 250 mg INQUIRY
Peptide C105Y TFA CDCCP23-120L 50 mg, 100 mg, 250 mg INQUIRY
Pep-1-Cysteamine CDCCP23-121L 50 mg, 100 mg, 250 mg INQUIRY
Products
Page Content
Fill out the form below
to receive a quote

GET A QUOTE

  • (USA)
  • (Europe)
Cookie Policy | Privacy Policy | Copyright © CD Bioparticles. All rights reserved.
×
Upload products to cart

1. Download the template.

2. Enter product information on the template (maximum number of products: 200).

3. Load the file using selector below.

Drag and drop your file here or

Choose file
*.xlsx (max 20 MB)

4. Click the "Add to cart" button.

×
Log In
×
Upload products to quote list

1. Download the template.

2. Enter product information on the template (maximum number of products: 200).

3. Load the file using selector below.

Drag and drop your file here or

Choose file
*.xlsx (max 20 MB)

4. Click the "Add to quote" button.